The Council brings leading public accounting firms together across the country to provide greater awareness of the noble mission of the USO and raise funds.
Women who spent years being told to lean in, build networks, seek visibility and prove their value are increasingly hearing a new message: Adapt again.
Audit and advisory solutions provider Fieldguide announced Field Orchestrator, a long-horizon agent capable of completing substantive testing workflows.
Analysts and investors were unimpressed by Phase 2 data posted in the spring showing that an amylin analog developed by Roche and partner Zealand Pharma elicited 9% weight loss, less than Eli Lilly’s rival candidate. Executives from both companies told BioSpace that premium weight loss is not the point of petrelintide.
After discontinuing development of its lead asset, Fulcrum Therapeutics has provided more details on its restructure, with 48 of 57 employees headed out the door.
Novo Nordisk and Eli Lilly presented data extolling the benefits of their relative weight loss therapies in obesity-linked indications, while analysts at BMO Capital Markets were “encouraged” by the strategy communicated by Novo management.